08:01:42 AM Fri, April 18, 2025
Sinopharm
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech (SVA.O) to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday. Scientists worldwide are racing to ..
A protein-based COVID-19 vaccine made by Sinopharm, when given as a booster after two doses of an earlier shot from the Chinese firm, elicited a stronger antibody response against the Omicron variant than a third dose of the original, a study showed...
REUTERS A two-dose COVID-19 vaccine from China's Sinopharm was 50.4% effective in preventing infections in health workers in Peru when it was seeing a surge in cases fuelled by virus variants, and booster shots can be considered, a study found..
Saudi Arabia has decided to allow entry to foreign travellers fully vaccinated with either Sinopharm or Sinovac vaccines, provided that they also receive a booster shot of either of the four vaccines approved by the Kingdom, according to the country&..
.jpg)
Qatar Secures Place Among the World's Top 10 Wealthiest Nations
.jpg)
Hamad International Airport Witnesses Record Increase in Passenger Traffic
Saudi Arabia: Any visa holder can now perform Umrah
What are Qatar's Labour Laws on Annual Leave?
.jpg)
.jpg)
.png)
.jpg)
